# US 2023/0065745 A1 · Piperidine-2,6-dione derivatives which bind to cereblon, and methods of use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0065745 A1
- Document ID: US20230065745A1
- Status: Published application
- Kind: A1
- Application number: 17/780,894
- Filed: 2020-11-27
- Published: 2023-03-02
- Earliest claimed: 2019-11-27
- Assignees: Captor Therapeutics S.A.
- Applicants: Captor Therapeutics S.A.
- Inventors: Katarzyna KACZANOWSKA; Sylvain COTTENS; Roman PLUTA; Niall DICKINSON; Michal WALCZAK
- Web page: https://patentgrep.com/patent/US20230065745A1

## CPC

- A61K 31/4535: containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
- A61K 31/4525: containing a five-membered ring with oxygen as a ring hetero atom
- A61K 31/454: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A61K 31/4545: containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
- A61K 31/573: substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A61K 31/69: Boron compounds
- A61K 39/3955: {against proteinaceous materials, e.g. enzymes, hormones, lymphokines}
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 17/00: Drugs for dermatological disorders
- A61P 35/00: Antineoplastic agents
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D 409/12: linked by a chain containing hetero atoms as chain links
- C07D 409/14: containing three or more hetero rings
- C07D 413/12: linked by a chain containing hetero atoms as chain links
- C07D 417/12: linked by a chain containing hetero atoms as chain links
- C07D 471/04: Ortho-condensed systems
- C07D 487/04: Ortho-condensed systems
- C07D 495/04: Ortho-condensed systems
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention provides novel compounds which bind to cereblon, and methods of use thereof. The compounds are represented by Formulas (Ia), (Ib), (IIa) and (IIb), below: Formula (Ia), Formula (Ib), Formula (IIa), Formula (IIb).

## Claims

### Claim 1

A compound of Formula (Ia) or (Ib):
or a pharmaceutically acceptable salt or tautomer thereof,
wherein
each of X1 and X2 is independently O or S;
Z is O, S or NR2;
T is C═O or SO2;
each of Y1, Y2, Y3, and Y4 is independently N or CR,
wherein at least one of Y1, Y2 and Y3 in Formula (Ia) is CR, and at least one of Y1, Y2 and Y4 in Formula (Ib) is CR;
n is 0, 1 or 2;
L is hydrogen, alkyl, alkenyl, aryl, heteroaryl, benzyl, haloalkyl, haloalkenyl, —C(O)R″, —CH2C(O)OR″, —C(O)OR″, —C(O)NH2, —C(O)NHR″, —C(O)NR″2, —OR″, —NR″2, or —S(O)2R″;
each R is independently hydrogen, halogen, alkyl, cycloalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, heteroaryl, benzyl, haloalkyl, haloalkenyl, —NH2, —NHR″, —NR″2, —CH2NR″2, —NR″C(O)R″, —NR″C(O)CH2NR″2, —NR″C(O)CH2-heterocycloalkyl, —NR″C(O)CH(OH)R″, —CH2NR″C(O)OR″, —NR″C(O)OR″, —NR″SO2R″, —NO2, —CN, —C(O)R″, —C(O)OR″, —C(O)NH2, —C(O)NHR″, —C(O)NR″2, —OR″, —OC(O)R″, —OC(O)OR″, —OC(O)NH2, —OC(O)NHR″, —OC(O)NR″2, —NHC(S)NHR″, SR″, or —S(O)2R″, —S(O)2OR″, —S(O)2NH2, —S(O)2NHR″, or —S(O)2NR″2;
each R″ is independently hydrogen, alkyl, cycloalkyl, alkenyl, cycloalkenyl, aryl, heteroaryl, or benzyl;
R2 is hydrogen, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, heteroaryl, benzyl, haloalkyl, haloalkenyl, —NH2, —NHR″, —NR″2, —NR″C(O)R″, —N[C(O)R″]2, —NR″C(O)OR″, —NO2, —CN, —C(O)R″, —C(O)OR″, —C(O)NH2, —C(O)NHR″, —C(O)NR″2, —OR″, —OC(O)R″, —OC(O)OR″, —OC(O)NH2, —OC(O)NHR″, —OC(O)NR″2, —SR″, or —S(O)2R″, —S(O)2OR″, —S(O)2NH2, —S(O)2NHR″, or —S(O)2NR″2;
R1 is hydrogen, alkyl, cycloalkyl, alkenyl, cycloalkenyl, aryl, heteroaryl, or benzyl;
wherein when Z is O, then Y2 is CR′ and
wherein when the compound is of Formula (Ia), then
(i) when each of Y1, Y2 and Y3 is CR, then at least one of R is not H;
(ii) when Z is NR2, then Y2 and Y3 are CR;
(iii) when Z is S, then Y1 is not C—OMe and Y2 is not C—OMe;
(iv) when Z is S and Y1 is C—NHCOMe, then Y3 is not C—CH2NR″C(O)OR″;
(v) when Z is S and Y1 is N, then Y2 is not C—H, C-aryl or C—C(O)OR″; and
(vi) when Z is S and Y2 is N, then Y3 is C—NH2, C—NHR″, C—NR″2, C—NR″C(O)OR″, C—CH2NR″C(O)OR″, C-haloalkyl, C-tButyl, C—OR″, C—COOR″ or C—SR″; wherein when Y3 is C—NH2, C—NHR″ or C—NR″2, then Y1 is C—H;
and when the compound is of Formula (Ib), then:
(vii) when each of Y1, Y2 and Y4 is CR, then at least one of R is not H;
(viii) when Z is S, then Y1 is not C—COOH or C—NHC(O)Me, and Y4 is not C—Br;
(ix) when Z is S and Y2 is C—Br, then Y4 is C—OR″
(x) when Z is S, Y1 is N and Y2 is C—H or C—NH2, then Y4 is not C—H
(xi) when Z is S and Y1 is N, then Y2 is not C-halogen, C-alkyl, C-cycloalkyl, C-aryl, C-heteroaryl, C—CH2NH2, C—COOalkyl, or C—NHC(O)alkyl; (xii) when Z is NR2, then Y1, Y2 and Y4 are CR.

### Claim 2 (depends on 1)

The compound of claim 1, having the structure:

### Claim 3 (depends on 1)

The compound of claim 1, having the structure:

### Claim 4

The compound of any preceding claim, wherein each R is independently hydrogen, halogen, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, heteroaryl, benzyl, haloalkyl, haloalkenyl, —NH2, —NHR″, —NR″2, —NR″C(O)R″, —NR″C(O)CH(OH)R″, —NR″C(O)OR″, —NR″SO2R″, —NO2, —CN, —C(O)R″, —C(O)OR″, —C(O)NH2, —C(O)NHR″, —C(O)NR″2, —OR″, —OC(O)R″, —OC(O)OR″, —OC(O)NH2, —OC(O)NHR″, —OC(O)NR″2, —SR″, or —S(O)2R″, —S(O)2OR″, —S(O)2NH2, —S(O)2NHR″, or —S(O)2NR″2.

### Claim 5

The compound of any preceding claim, wherein T is C═O.

### Claim 6 (depends on 1, 2, 3, 4)

The compound of any one of claims 1-4, wherein T is SO2.

### Claim 7

The compound of any preceding claim, wherein Z is S or NR2.

### Claim 8 (depends on 7)

The compound of claim 7, wherein Z is NR2.

### Claim 9

The compound of any preceding claim, wherein R2 is alkyl, benzyl, or —N[C(O)R″]2.

### Claim 10 (depends on 7)

The compound of claim 7, wherein Z is S.

### Claim 11

The compound of any preceding claim, wherein L is hydrogen, alkyl, alkenyl, haloalkyl, haloalkenyl, —C(O)R″, —CH2C(O)OR″, —C(O)OR″, —C(O)NH2, —C(O)NHR″, —C(O)NR″2, —OR″, —NR″2, or —S(O)2R″.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The compound of any one of claims 1-10, wherein L is hydrogen, alkyl, alkenyl, —CH2C(O)OR″, —OR″, —NR″2, or —S(O)2R″; optionally wherein L is hydrogen, alkyl, or alkenyl.

### Claim 13 (depends on 12)

The compound of claim 12, wherein L is hydrogen, alkyl, —CH2C(O)OR″ or —OR″.

### Claim 14 (depends on 13)

The compound of claim 13, wherein L is hydrogen.

### Claim 15

The compound of any preceding claim, wherein the compound is of Formula (Ia), wherein one of Y2 and Y3 is N, and the remaining two of Y1, Y2 and Y3 are each CR.

### Claim 16 (depends on 15)

The compound of claim 15, wherein Y1 is N, and Y2 and Y3 are CR.

### Claim 17 (depends on 15)

The compound of claim 15, wherein Y2 is N, and Y1 and Y3 are CR; and Z is S.

### Claim 18 (depends on 15)

The compound of claim 15, wherein Y3 is N; Y1 and Y2 are CR; and Z is S.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The compound of any one of claims 1-14, wherein the compound is of Formula (Ia), wherein one of Y1, Y2 and Y3 is CR, the remaining two of Y1, Y2 and Y3 are each N; and Z is S.

### Claim 20 (depends on 19)

The compound of claim 19, wherein Y1 is CR; Y2 and Y3 are N.

### Claim 21 (depends on 19)

The compound of claim 19, wherein Y2 is CR; Y1 and Y3 are N.

### Claim 22 (depends on 19)

The compound of claim 19, wherein Y3 is CR, and Y1 and Y2 are N.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The compound of any one of claims 1-14, wherein the compound is of Formula (Ia) and Y1, Y2 and Y3 are each CR.

### Claim 24 (depends on 23)

The compound of claim 23, wherein
Y1 is —C—NHC(O)R″,
Y2 is CH, and
Y3 is CH or CCl.

### Claim 25 (depends on 24)

The compound of claim 24, wherein:
L is hydrogen;
Z is S;
R1 is H;
T is C═O;
Y1 is —C—NHC(O)R″;
Y2 is CH; and
Y3 is CH.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The compound of any one of claims 1-14, wherein the compound is of Formula (Ib), wherein one of Y1, Y2 and Y4 is N and the remaining two of Y1, Y2 and Y4 are each CR, and wherein Z is S.

### Claim 27 (depends on 26)

The compound of claim 26, wherein Y1 is N, and Y2 and Y4 are CR.

### Claim 28 (depends on 26)

The compound of claim 26, wherein Y2 is N, and Y1 and Y4 are CR.

### Claim 29 (depends on 26)

The compound of claim 26, wherein Y4 is N, and Y1 and Y2 are CR.

### Claim 30 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The compound of any one of claims 1-14, wherein the compound is of Formula (Ib), wherein one of Y1, Y2 and Y4 is CR and the remaining two of Y1, Y2 and Y4 are each N, and wherein Z is S.

### Claim 31 (depends on 30)

The compound of claim 30, wherein Y1 is CR, and Y2 and Y4 are N.

### Claim 32 (depends on 30)

The compound of claim 30, wherein Y2 is CR, and Y1 and Y4 are N.

### Claim 33 (depends on 30)

The compound of claim 30, wherein Y4 is CR, and Y1 and Y2 are N.

### Claim 34 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The compound of any one of claims 1-14, wherein the compound is of Formula (Ib) and Y1, Y2 and Y4 are each CR.

### Claim 35 (depends on 34)

The compound of claim 34, wherein each R is independently hydrogen, halogen, alkyl, cycloalkyl, haloalkyl, heteroaryl, —OR″, —N[C(O)R″]2, —NR″C(O)R″, —NHC(O)OR″, —NHR″, —NH2, or —NHSO2R″CN;
optionally wherein each R″ is independently alkyl, cycloalkyl, aryl or benzyl.

### Claim 36 (depends on 35)

The compound of claim 35, wherein:
L is hydrogen;
Z is 5;
R1 is H;
T is C═O;
Y1 is CH, C—OR″, CCl, C—CN, or C—NHC(O)R″;
Y2 is CH, CCl, C-alkyl, C-cycloalkyl, or C-haloalkyl; and
Y4 is CH, C—OR″, C—NHC(O)R″, C—NHC(O)OR″, C—NHR″, C—NH2, or C—NHSO2R″;
wherein, when Y1 is CCl, then Y2 is CH, C-alkyl, C-cycloalkyl, or C-haloalkyl;
optionally wherein each R″ is independently alkyl, cycloalkyl, aryl or benzyl.

### Claim 37 (depends on 36)

The compound of claim 36, wherein:
Y1 is CH;
Y2 is CH or CCl; and
Y4 is C—OR″ or C—NH2, optionally C—OMe or C—NH2.

### Claim 38 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The compound of any one of claims 1-35, wherein each R is independently hydrogen, halogen, alkyl, cycloalkyl, haloalkyl, heteroaryl, —NR″C(O)R″, NR″C(O)OR″, —NR″C(O)CH(OH)R″, —NHR″, —NH2, —OR″, —CN, —C(O)NR″2, or —NR″SO2R″.

### Claim 39 (depends on 38)

The compound of claim 38, wherein each R is independently hydrogen, halogen, alkyl, cycloalkyl, haloalkyl, —OR″, —CN, —NHC(O)R″, —NHC(O)OR″, —NHR″, —NH2 or —NHSO2R″.

### Claim 40 (depends on 38, 39)

The compound of claim 38 or 39, wherein each R″ is independently alkyl, cycloalkyl, aryl or benzyl.

### Claim 41 (depends on 1, 2, 3)

The compound of any one of claims 1-3, wherein compound is of Formula (Ia), and wherein:
X1 and X2 are O
T is C═O
n is 1
R1 is hydrogen
L is hydrogen, and
Z is S,
wherein,
when Y1 and Y3 are CR, then
(a) Y2 is CH, Y3 is CH, and Y1 is C—NHC(O)R″;
(b) Y1 is CH, Y3 is CH, and Y2 is C—OH or C—CH2NHC(O)OR″; or
(c) Y1 is CH, Y2 is CH, and Y3 is C—CH2NHC(O)OR″; and
when Y2 is N, then Y3 is C—NHC(O)OR″ or C—NH2.

### Claim 42 (depends on 1, 2, 3)

The compound of any one of claims 1-3, wherein the compound is of Formula (Ib), and wherein:
X1 and X2 are O
T is C═O
n is 1
R1 is hydrogen
L is hydrogen
Z is S, and
Y2 and Y4 are CR,
wherein:
when Y1 is N, then Y2 is CH, C—NH2 or C—CH2NHC(O)OR″ and Y4 is CH or C—OR″, wherein at least one of Y2 and Y4 is not CH; and
when Y1, Y2 and Y4 are each CR, then
Y1 is CH, C-alkyl, C—Cl or C—OR″
Y2 is CH, C-halogen, C-cycloalkyl, C-haloalkyl, C-aryl, C—CONH(R″), or C—CN
Y4 is CH, C—NH2, C—NHR″, C—NR″C(O)R″, C—NR″SO2R″, or C—OR″;
at least one of Y1, Y2 and Y4 is CH or C—Cl; and
(a) when Y1 and Y2 are CH, then Y4 is C—NHCOR″, C—NHSO2R″, C—OR″, or C—NH2,
(b) when Y4 is C—NHCOR″ and Y1 is C—Cl, then Y2 is C-cycloalkyl, and
(c) when Y1 and Y2 are CH and Y4 is C—OMe, then the compound is:

### Claim 43

A compound of Formula (IIa) or (IIb):
or a pharmaceutically acceptable salt or tautomer thereof,
wherein
each of X1 and X2 is independently O or S;
Z is O, S or NR2;
T is C═O or SO2;
Y3 is N or CR;
Y4 is N or CR;
indicates a single or double bond, wherein
when each is a double bond, each of W1, W2, W3 and W4 is independently N or CR′, wherein at least one of W1, W2, W3 and W4 is N, and
when each is a single bond, W1, W2, W3 and W4 are each CR′2 and Y4 is CR;
n is 0, 1 or 2;
L is hydrogen, alkyl, alkenyl, aryl, heteroaryl, benzyl, haloalkyl, haloalkenyl, —C(O)R″, —C(O)OR″, —C(O)NH2, —C(O)NHR″, —C(O)NR″2, —OR″, —NR″2, or —S(O)2R″;
each R is independently hydrogen, halogen, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, heteroaryl, benzyl, haloalkyl, haloalkenyl, —NH2, —NHR″, —NR″2, —NR″C(O)R″, —NR″C(O)CH2R″, —NR″C(O)CH(OH)R″, —NR″C(O)OR″, —NR″SO2R″, —NO2, —CN, —C(O)R″, —C(O)OR″, —C(O)NH2, —C(O)NHR″, —C(O)NR″2, —OR″, —OC(O)R″, —OC(O)OR″, —OC(O)NH2, —OC(O)NHR″, —OC(O)NR″2, —SR″, or —S(O)2R″, —S(O)2OR″, —S(O)2NH2, —S(O)2NHR″, or —S(O)2NR″2;
each R′ is independently hydrogen, halogen, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, heteroaryl, benzyl, haloalkyl, haloalkenyl, —NH2, —NHR″, —NR″2, —NR″C(O)R″, —NR″C(O)CH(OH)R″, —NR″C(O)OR″, —NR″SO2R″, —NO2, —CN, —C(O)R″, —C(O)OR″, —C(O)NH2, —C(O)NHR″, —C(O)NR″2, —OR″, —OC(O)R″, —OC(O)OR″, —OC(O)NH2, —OC(O)NHR″, —OC(O)NR″2, —SR″, or —S(O)2R″, —S(O)2OR″, —S(O)2NH2, —S(O)2NHR″, or —S(O)2NR″2;
each R″ is independently hydrogen, alkyl, cycloalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, aryl, heteroaryl, or benzyl;
R2 is hydrogen, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, heteroaryl, benzyl, haloalkyl, haloalkenyl, —NH2, —NHR″, —NR″2, —NR″C(O)R″, —N[C(O)R″]2, —NR″C(O)OR″, —NO2, —CN, —C(O)R″, —C(O)OR″, —C(O)NH2, —C(O)NHR″, —C(O)NR″2, —OR″, —OC(O)R″, —OC(O)OR″, —OC(O)NH2, —OC(O)NHR″, —OC(O)NR″2, —SR″, or —S(O)2R″, —S(O)2OR″, —S(O)2NH2, —S(O)2NHR″, or —S(O)2NR″2; and
R1 is hydrogen, alkyl, cycloalkyl, alkenyl, cycloalkenyl, aryl, heteroaryl, or benzyl;
wherein when each is a double bond, Z is NR2, R2 is hydrogen, and each R′ is hydrogen, then W4 is CR′.

### Claim 44 (depends on 43)

The compound of claim 43, wherein the compound is of Formula (IIa).

### Claim 45 (depends on 43)

The compound of claim 43, wherein the compound is of Formula (IIb).

### Claim 46 (depends on 43)

The compound claim 43, having the structure:

### Claim 47 (depends on 43)

The compound claim 43, having the structure:

### Claim 48 (depends on 43, 44, 45, 46, 47)

The compound of any one of claims 43-47, wherein when each is a double bond, Z is NR2, R2 is hydrogen, and Y3 and Y4 are CR, one of W1, W2, W3 and W4 is N, and the remaining three of W1, W2, W3 and W4 are each CR′, then at least one R′ is not hydrogen

### Claim 49 (depends on 43, 44, 45, 46, 47, 48)

The compound of any one of claims 43-48, wherein Z is O.

### Claim 50 (depends on 43, 44, 45, 46, 47, 48)

The compound of any one of claims 43-48, wherein Z is S.

### Claim 51 (depends on 43, 44, 45, 46, 47, 48)

The compound of any one of claims 43-48, wherein Z is NR2.

### Claim 52 (depends on 43, 44, 45, 46, 47, 48, 49, 50, 51)

The compound of any one of claims 43-51, wherein T is C═O.

### Claim 53 (depends on 43, 44, 45, 46, 47, 48, 49, 50, 51)

The compound of any one of claims 43-51, wherein T is SO2.

### Claim 54 (depends on 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53)

The compound of any one of claims 43-53, wherein L is hydrogen, alkyl, alkenyl, aryl, heteroaryl, benzyl, haloalkyl, haloalkenyl, —C(O)R″, —C(O)OR″, —C(O)NH2, —C(O)NHR″, —C(O)NR″2, —NR″2, or —S(O)2R″; optionally wherein L is hydrogen, alkyl, alkenyl, aryl, heteroaryl, benzyl, —NR″2, or —S(O)2R″

### Claim 55 (depends on 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53)

The compound of any one of claims 43-53, wherein L is hydrogen, alkyl, alkenyl, aryl, heteroaryl, benzyl, —OR″, —NR″2, or —S(O)2R″; optionally wherein L is hydrogen, alkyl, alkenyl, aryl, heteroaryl, or benzyl.

### Claim 56 (depends on 55)

The compound of claim 55, wherein L is hydrogen.

### Claim 57 (depends on 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56)

The compound of any one of claims 43-56, wherein Y3 is N.

### Claim 58 (depends on 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56)

The compound of any one of claims 43-56, wherein Y3 is CR.

### Claim 59 (depends on 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56)

The compound of any one of claims 43-56, wherein Y4 is N.

### Claim 60 (depends on 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56)

The compound of any one of claims 43-56, wherein Y4 is CR.

### Claim 61 (depends on 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60)

The compound of any one of claims 43-60, wherein each is a double bond or wherein each is a single bond.

### Claim 62 (depends on 61)

The compound of claim 61, wherein each is a double bond.

### Claim 63 (depends on 62)

The compound of claim 62, wherein one of W1, W2, W3 and W4 is N, and the remaining three of W1, W2, W3 and W4 are each CR′.

### Claim 64 (depends on 63)

The compound of claim 63, wherein one of W1, W2 and W3 is N, and W4 is CR′.

### Claim 65 (depends on 62)

The compound of claim 62, wherein two of Ali, W2, W3 and W4 is N, and the remaining two of W1, W2, W3 and W4 are each CR′.

### Claim 66 (depends on 62)

The compound of claim 62, wherein one of W1, W2, W3 and W4 is CR′, and the remaining three of W1, W2, W3 and W4 are each N.

### Claim 67 (depends on 61)

The compound of claim 61, wherein each is a single bond.

### Claim 68 (depends on 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67)

The compound of any one of claims 43-67, wherein each R is independently hydrogen, halogen or —NR″C(O)R″.

### Claim 69 (depends on 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68)

The compound of any one of claims 43-68, wherein at least one R′ is not hydrogen.

### Claim 70 (depends on 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68)

The compound of any one of claims 43-68, wherein each R′ is hydrogen.

### Claim 71 (depends on 43, 44, 46, 47)

The compound of any one of claim 43, 44, 46 or 47, wherein the compound is of Formula (IIa), and wherein:
X1 and X2 are O
T is C═O
n is 1
R1 is hydrogen
L is hydrogen
Z is S
each is a double bond
W1 is N
W2, W3 and W4 are each independently CH or C—Cl; and
Y3 is CH or C-halogen.

### Claim 72 (depends on 43, 45, 46, 47)

The compound of any one of claims 43 and 45-47, wherein the compound is of Formula (IIb), and wherein:
X1 and X2 are O
T is C═O
n is 1
R1 is hydrogen
L is hydrogen
Z is NH
each is a double bond
W4 is N
W3 is CH
one of W1 and W2 is C—Cl, and the other of W1 and W2 is CH; and
Y4 is CH.

### Claim 73

The compound of any preceding claim, wherein X1 and X2 are O.

### Claim 74 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70)

The compound of any one of claims 1-70 wherein X1 is O and X2 is S.

### Claim 75 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70)

The compound of any one of claims 1-70, wherein X1 is S and X2 is O.

### Claim 76 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70)

The compound of any one of claims 1-70, wherein X1 and X2 are S.

### Claim 77

The compound of any preceding claim, wherein n is 0.

### Claim 78 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76)

The compound of any one of claims 1-76, wherein n is 1 or 2.

### Claim 79 (depends on 78)

The compound of claim 78, wherein n is 1.

### Claim 80 (depends on 78)

The compound of claim 78, wherein n is 2.

### Claim 81

A compound of any one of the preceding claims, for use as a cereblon binder.

### Claim 82 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80)

A pharmaceutical composition comprising a compound of any one of claims 1-80.

### Claim 83 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 82)

A compound of any one of claims 1-80, a composition according to claim 82, or a compound selected from
for use in medicine.

### Claim 84 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 82)

A compound of any one of claims 1-80, a composition according to claim 82, or a compound selected from
for use in immune-oncology.

### Claim 85 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 82)

A compound of any one of claims 1-80, a composition according to claim 82, or a compound selected from
for use in the treatment of cancer, autoimmune diseases, macular degeneration (MD) and related disorders, diseases and disorders associated with undesired angiogenesis, skin diseases, pulmonary disorders, asbestos-related disorders, parasitic diseases and disorders, immunodeficiency disorders, atherosclerosis and related conditions, hemoglobinopathy and related disorders, or TNFα related disorders.

### Claim 86 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 83, 84)

The compound or composition for use of any one of claims 83-84, wherein the compound is a compound of any one of claims 1-80.

### Claim 87 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 82)

A method for the treatment of cancer, autoimmune diseases, macular degeneration (MD) and related disorders, diseases and disorders associated with undesired angiogenesis, skin diseases, pulmonary disorders, asbestos-related disorders, parasitic diseases and disorders, immunodeficiency disorders, atherosclerosis and related conditions, hemoglobinopathy and related disorders, or TNFα related disorders;
wherein the method comprises administering to a patient in need thereof an effective amount of compound of any one of claims 1-80, a composition according to claim 82, or a compound selected

### Claim 88 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 82, 87)

The method of claim 87, wherein an effective amount of compound of any one of claims 1-80, or a composition according to claim 82, is administered to the patient.

### Claim 89 (depends on 87, 88)

The method of any one of claims 87-88, further comprising administering at least one additional active agent to the patient.

### Claim 90 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80)

A combined preparation of a compound of any one of claims 1-80 or a compound selected from
and at least one additional active agent, for simultaneous, separate or sequential use in therapy.

### Claim 91 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80)

A combined preparation of a compound of any one of claims 1-80 and at least one additional active agent, for simultaneous, separate or sequential use in therapy.

### Claim 92 (depends on 89, 90)

The combined preparation of any one of claims 89-90, or the method of claim 89, wherein the at least one additional active agent is an anti-cancer agent or an agent for the treatment of an autoimmune disease.

### Claim 93 (depends on 89, 90, 91, 92)

The combined preparation of any one of claims 89-92, or the method of claim 89 or 92, wherein the at least one additional active agent is a small molecule, a peptide, an antibody, a corticosteroid, or a combination thereof.

### Claim 94 (depends on 93)

The combined preparation or method of claim 93, wherein the at least one additional active agent is at least one of bortezomib, dexamethasone, and rituximab.

### Claim 95 (depends on 90, 91, 92, 93, 94)

The combined preparation of any one of claims 90-94 wherein the therapy is the treatment of cancer, autoimmune diseases, macular degeneration (MD) and related disorders, diseases and disorders associated with undesired angiogenesis, skin diseases, pulmonary disorders, asbestos-related disorders, parasitic diseases and disorders, immunodeficiency disorders, atherosclerosis and related conditions, hemoglobinopathy and related disorders, or TNFα related disorders.
